Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Industry experts predicts tough choices as NewJeans' ultimatum nears

    Industry experts predicts tough choices as NewJeans' ultimatum nears
  2. 2

    Jung's paternity reveal exposes where Korea stands on extramarital babies

    Jung's paternity reveal exposes where Korea stands on extramarital babies
  3. 3

    Seoul city opens emergency care centers

    Seoul city opens emergency care centers
  4. 4

    Opposition chief acquitted of instigating perjury

    Opposition chief acquitted of instigating perjury
  5. 5

    Samsung entangled in legal risks amid calls for drastic reform

    Samsung entangled in legal risks amid calls for drastic reform
  1. 6

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'
  2. 7

    [Exclusive] Hyundai Mobis eyes closer ties with BYD

    [Exclusive] Hyundai Mobis eyes closer ties with BYD
  3. 8

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
  4. 9

    [Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance

    [Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance
  5. 10

    Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push

    Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push
지나쌤

3 Korean brokerages buy Novo Nordisk’s US HQ building

By Korea Herald

Published : June 29, 2016 - 14:52

    • Link copied

[THE INVESTOR] Three Korean securities firms have decided to jointly acquire a pharmaceutical company’s headquarters building in the US for 350 billion won (US$301 million) as a part of their real estate investment, sources said on June 29.

Mirae Asset Daewoo, Hana Financial Investment and HMC Investment & Securities will buy the building used by Novo Nordisk, Danish pharmaceutical company, which signed a 15-year lease on the property in 2011.

Located in New Jersey, the 68,000 square-meter building is expected to generate annual return of 7 percent.

By Park Han-na (hnpark@heraldcorp.com)

More from Headlines